|
WO2016081457A2
|
|
Recombinant human ada2 and ada2 fusion proteins and methods for treating ada2 deficiencies
|
|
WO2016077356A2
|
|
Therapeutic compositions of alpha-l-iduronidase, iduronate-2-sulfatase, and alpha-galactosidase a and methods of use thereof
|
|
AU2015249135A1
|
|
Lysosomal storage disease enzyme
|
|
AU2014216037A1
|
|
Transgenic chickens
|
|
US2013330317A1
|
|
Methods for Treating Lysosomal Acid Lipase Deficiency
|
|
US2014298503A1
|
|
Glycosylation in Avians
|
|
US2015098933A1
|
|
Truncated lysosomal acid lipase
|
|
KR20140108519A
|
|
Recombinant human naglu protein and uses thereof
|
|
AU2012301820A1
|
|
Transgenic birds that produce chimeric human immunoglobulins
|
|
AU2012201824A1
|
|
Transgenic chickens
|
|
EP2675472A1
|
|
Methods for treating lysosomal acid lipase deficiency
|
|
KR20140043726A
|
|
Npp1 fusion proteins
|
|
NZ700824A
|
|
Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
|
|
KR20130136990A
|
|
Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
|
|
CA2995446A1
|
|
Lysosomal storage disease enzyme
|
|
WO2011113027A2
|
|
Npp1 fusion proteins
|
|
EP2435476A2
|
|
Avian derived antibodies
|
|
US2010333219A1
|
|
Methods of protein production using ovomucoid regulatory regions
|
|
US2010041039A1
|
|
Analysis of nucleic acid obtained from nucleated red blood cells
|
|
US2009180989A1
|
|
Compositions and methods for delivering nucleotide sequences to vertebrates
|
